Literature DB >> 8047068

Human AT1 receptor is a single copy gene: characterization in a stable cell line.

N Aiyar1, E Baker, H L Wu, P Nambi, R M Edwards, J J Trill, C Ellis, D J Bergsma.   

Abstract

To address conflicting reports concerning the number of angiotensin II (AII) receptor type 1 (AT1) coding loci in vertebrates, Southern blot analysis was used to determine the genomic representation of AT1 receptor genes in animals comprising a divergent evolutionary spectrum. The data demonstrate that the AT1 receptor gene is present as a single genomic copy in a broad spectrum of animals including human, monkey, dog, cow, rabbit, and chicken. In contrast, members of the rodent taxonomic order contain two genes in their genomes. These two genes may have arisen in rodents as a consequence of a gene duplication event that occurred during evolution following the branching of rodents from the mammalian phylogenetic tree. In order to investigate the properties of the human AT1 receptor in a pure cell system, the recombinant human AT1 receptor was stably expressed in mouse L cells. An isolated cell line, designated LhAT1-D6, was found to express abundant levels of recombinant receptor [430 +/- 15 fmol/mg] exhibiting high affinity [KD = 0.15 +/- 0.02 nM] for [125I][SAR1, Ile8] angiotensin II (SIA). The pharmacological profile of ligands competing for [125I] SIA binding to the expressed receptor was in accordance with that of the natural receptor. Radioligand binding of the expressed receptor was decreased in the presence of the non-hydrolyzable analog of GTP, guanosine 5'-(gamma-thio) triphosphate [GTP gamma S]. Angiotensin II evoked a rapid efflux of 45Ca2+ from LhAT1-D6 cells that was blocked by AT1 receptor specific antagonists. In addition, AII inhibited forskolin-stimulated cAMP accumulation in these cells which was blocked by the AT-1 antagonist. Thus, the LhAT1-D6 cell line provides a powerful tool to explore the human AT1 receptor regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8047068     DOI: 10.1007/bf01075727

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  48 in total

Review 1.  Nonpeptide angiotensin II receptor antagonists.

Authors:  P B Timmermans; P C Wong; A T Chiu; W F Herblin
Journal:  Trends Pharmacol Sci       Date:  1991-02       Impact factor: 14.819

2.  Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor.

Authors:  R Takayanagi; K Ohnaka; Y Sakai; R Nakao; T Yanase; M Haji; T Inagami; H Furuta; D F Gou; M Nakamuta
Journal:  Biochem Biophys Res Commun       Date:  1992-03-16       Impact factor: 3.575

3.  Angiotensin II receptor antagonists and receptor subtypes.

Authors:  P C Wong; A T Chiu; J V Duncia; W F Herblin; R D Smith; P B Timmermans
Journal:  Trends Endocrinol Metab       Date:  1992-08       Impact factor: 12.015

Review 4.  Renin-angiotensin system: biochemistry and mechanisms of action.

Authors:  M J Peach
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

5.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

6.  Maximum parsimony approach to construction of evolutionary trees from aligned homologous sequences.

Authors:  J Czelusniak; M Goodman; N D Moncrief; S M Kehoe
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

7.  Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line.

Authors:  N Aiyar; P Nambi; F L Stassen; S T Crooke
Journal:  Life Sci       Date:  1986-07-07       Impact factor: 5.037

8.  Identification of two subtypes in the rat type I angiotensin II receptor.

Authors:  N Iwai; T Inagami
Journal:  FEBS Lett       Date:  1992-02-24       Impact factor: 4.124

9.  Cloning and expression of a novel angiotensin II receptor subtype.

Authors:  K Sandberg; H Ji; A J Clark; H Shapira; K J Catt
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

Review 10.  Mechanisms of action of calcium-mobilizing agonists: some variations on a young theme.

Authors:  J H Exton
Journal:  FASEB J       Date:  1988-08       Impact factor: 5.191

View more
  9 in total

1.  The human GABA(B1b) and GABA(B2) heterodimeric recombinant receptor shows low sensitivity to phaclofen and saclofen.

Authors:  M D Wood; K L Murkitt; S Q Rice; T Testa; P K Punia; M Stammers; O Jenkins; N A Elshourbagy; U Shabon; S J Taylor; T L Gager; J Minton; W D Hirst; G W Price; M Pangalos
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

Review 2.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

3.  Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.

Authors:  M J Orsini; C M Debouck
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 4.  Eprosartan: a review of its use in the management of hypertension.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

5.  The rev-responsive element negatively regulates human immunodeficiency virus type 1 env mRNA expression in primate cells.

Authors:  M J Churchill; J L Moore; M Rosenberg; D W Brighty
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  Calcitonin gene-related peptide receptor independently stimulates 3',5'-cyclic adenosine monophosphate and Ca2+ signaling pathways.

Authors:  N Aiyar; J Disa; J M Stadel; P G Lysko
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

7.  Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.

Authors:  Nabil A Elshourbagy; Stephen A Douglas; Usman Shabon; Stephen Harrison; Graham Duddy; Jan L Sechler; Zhaohui Ao; Beverly E Maleeff; Diane Naselsky; Jyoti Disa; Nambi V Aiyar
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

8.  Augmented renal vascular nNOS and renin protein expression in angiotensin type 1 receptor null mice.

Authors:  Sungmi Park; Lisa M Harrison-Bernard
Journal:  J Histochem Cytochem       Date:  2008-01-07       Impact factor: 2.479

9.  Ligand modulated antagonism of PPARgamma by genomic and non-genomic actions of PPARdelta.

Authors:  Mattias C U Gustafsson; Deborah Knight; Colin N A Palmer
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.